N E W S B Y T E S
CSIR-CDRI collaborates with Bengaluru based startup to develop novel therapeutics for cancer treatment
Sravathi AI Technology , a leading Indian startup in artificial intelligence ( AI ) -based drug discovery , and CSIR- CDRI ( Central Drug Research Institute ), Lucknow have announced a strategic collaboration to develop new therapeutics for the treatment of cancer . Bangaluru based Sravathi AI Technology is focused on creating , discovering , and developing innovative advanced pharma and chemical products . Sravathi AI uses Hybrid Intelligence , combining the brilliance of the human mind and domain expertise with innovative AI technology to solve the most difficult problems .
The collaboration will entail the use of advanced artificial intelligence and computational tools developed at Sravathi to design novel chemical entities ( NCEs ) with anti-cancer properties . CSIR-CDRI Lucknow will validate these predictions by synthesizing the NCEs and performing the required biological evaluation in vitro and in vivo .
Biotech startup Mestastop raises US $ 500k to further its cancer drug discovery & repurposing technology
Mestastop Solutions , a biotechnology startup , has raised Rs 4.5cr or $ 500k in a Pre Series A round led by 92 angels & Malpani Ventures . In 2021 the company had secured a seed funding of Rs 2cr led by IIM Ahmedabad ’ s CIIE with participation from IKP and angel investors . Founded by Arnab Roy Chowdhury and Debabani Roy Chowdhury , Mestastop is creating a cancer metastasis focussed platform , which uses wet lab biology and predictive analytics to identify and distinguish unique properties of metastasis and leverage them for drug discovery and patient treatment .
Dr Arnab ’ s shared “ We are ready to leap forward and use these platforms for our discovery and diagnostics efforts . I thank all existing investors for supporting us and the incoming investors for sharing our vision and passion . ”
46
BioVoiceNews | November / December 2023